5 Dividend Stocks to Buy According to Bernard Horn’s Polaris Capital

4. AbbVie Inc. (NYSE:ABBV)

Polaris Capital’s Stake Value: $52.32 million

Percentage of Polaris Capital’s 13F portfolio: 1.66%

Total Number of Hedge Fund Holders: 81

Dividend Yield: 4.84%

Then we have AbbVie Inc. (NYSE: ABBV), a research-based pharmaceutical company that develops, manufactures, and sells pharmaceutical products around the world. As reported by the end of September, Bernard Horn owns 485,115 shares in AbbVie Inc. (NYSE: ABBV), at a value of $52.32 million which represents a 1.66% slice of his overall portfolio.

For Q3 2021, the company reported an EPS of $3.33, beating estimates by $0.11.

As of the third quarter of 2021, 81 hedge funds reported owning shares in AbbVie Inc. (NYSE: ABBV), with a combined value of $4.14 billion.

On November 24, research firm Truist maintained its ‘Buy’ rating on the company stock, raising the price target to $135 from $118. The firm’s analyst Robyn Karnauskas noted that the FDA’s labeling discussion for RA was one of the catalysts for the company’s growth in 2021.